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Abstract 
The human behavior and cognition are the two most important functions for human life in 
the society. The cognitive function is declined in the elderly, but it is not always the case. 
Fluid intelligence may decline along with aging but crystalized intelligence can be 
maintained even in the elderly. 
In addition to neurocognitive disorders (dementia), cognitive function is impaired with 
various psychiatric disorders and it will be the main target for future psychiatry. Due to 
the knowledge obtained from the recent development in brain mapping, psychiatrists can 
perceive and understand the meaning of the psychiatric symptoms based upon the 
dysfunction of these networks. Subjective experience of the patients should be paid more 
attention by closer collaboration between psychiatrists/ researchers and patients/ 
families. 
Elucidating the brain network representing common sense will be important. Psy-
chiatrists are recommended to expand the range of the frame of their common sense to be 
able to understand the meaning of the patient behavior. 
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 The human beings have evolved the central 
nervous system (CNS) and the immune system to 
produce the optimal behavior or response to the 
stimuli from outside world to incorporate en-
vironmental factors to their life. The CNS defines 
our behavior to outside stimuli, and the immune 
system regulates the appropriate biological 
response of the organ to ambient conditions. 
 Psychiatry is a discipline of medicine mainly 
dealing with abnormal behavior of human sub-
jects, and action and behavior of the subject is 
produced and modulated by the CNS responding 
to various factors. In the CNS, the substances of 
various levels (gene, protein, cell, tissue, or organ) 
are involved with the process of behavior 
production which is finely modulated by the 
crosstalk among neurotransmitters, hormones, 
and cytokines. To understand the mechanism of
abnormal behavior of human beings, psychiatrists 
need to integrate the knowledge on various 
biological, psychological and social factors. There-
fore, we believe that multilayered psycho-
pathology is essential in psychiatry
Humans engage social life utilizing behavior as 
the currency
 Abnormal behavior of subject is the primary 
target of psychiatry. Humans live in the society 
producing various behaviors, and the behavior 
itself functions in the society just as the currency 
does. Humans choose the appropriate behavior 
by recognizing the stimuli from the outside world, 
and cognition and behavior of the subject are 
functioning as the currency in social life, respond-
ing each other (Fig. 1).
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A. Human behavior and cognition. 
Humans live in the society using behavior as the currency does in the society. An individual 
perceives the stimuli from the outside world by cognitive function, which is utilized to modulate 
behavior responding to the society. 
B. Modulation of human behavior by conscious and unconscious factors. 
Human behavior is modulated by the combination of conscious and unconscious factors. The typical 
conscious behavior is produced responding to the stimuli from the outside world. The response to 
the stimuli is also modulated by the psychological state, education, habits, or taste of the individual. 
Of course, the character of the individual affects the content of the behavior. Further, medicine 
acting to the CNS or psychiatric disorders significantly affects the behavior of the individual. 
                             Fig. 1
 Human behavior is sometimes unconsciously 
performed. For example, the reaction to the 
stimuli from the world outside can be modulated 
by psychological state of the subject, often 
showing different reactions to the same stimuli. 
Even if the external stimulus is the same, humans 
may show different behavior depending on the 
level of education, the contents of the past 
experience, habits, taste, or personality of the 
subject. Such volitional behaviors are primarily 
performed on the conscious level, but it is not 
usually perceived subjectively that the behavior is 
influenced by unconscious factors. 
 Drugs acting on the CNS should also be 
mentioned as a possible factor with significant 
impact on the behavior and cognition, Psychiatric 
disorder also causes significant changes in the 
behavior which might be caused by the change in 
cognition, resulting in the specific set of be-
havioral patterns unique to each psychiatric 
disorder. Abnormal behavior is a direct target of 
psychiatry, and cognitive function is also the one 
at the same token.
Definition of cognitive function 
 Cognition can be defined in broader or 
narrower senses depending on the context. 
Generally speaking, it can be defined as the 
function to choose the appropriate human be-
havior corresponding to the stimuli and informa-
tion from outside. In other words, the cognitive 
function may collectively include all intellectual 
function of humans including language, calcula-
tion, memory, learning, and problem-solving. The 
input information from outside is accepted by the
primary sensory cortex of the brain, delivered to 
the secondary sensory cortex, and finally to the 
associated sensory cortex where the information 
from outside is processed to produce the most 
appropriate behavior. The processed information 
in the association cortex is collated with the 
information stored inside the limbic system of the 
brain, and the output is firstly determined in the 
association motor cortex, then delivered to the 
primary motor cortex through the secondary 
motor cortex. The information processing in the 
brain, flowing from the rear to the front of the 
cerebrum, is the core process of the cognitive 
function. In narrower meaning, the cognitive 
function is carried out in the association sensory, 
association motor and memory area of the brain. 
In case of broader meaning, however, the cogni-
tive function might also refer to the entire 
cerebral cortex. In general, the cognitive function 
can represent function of the higher brain 
function such as memory, learning, language, and 
executive function (Fig. 2). 
 Cognitive impairment is defined in the fourth 
edition of the Diagnostic and Statistical Manual of 
Mental Disorder  (DSM-4) as the dysfunction in 
either one or more domains of cognitive function; 
memory impairment, aphasia, apraxia, or execu-
tive dysfunction. In  DSM-5, six domains of cogni-
tive function are listed: (complex) attention, ex-
ecutive function, memory and learning, language, 
perceptual-motor, as well as social cognition. Neu-
rocognitive disorder is defined as the impairment 
in one or more domains of cognitive function in 
 DSM-5.
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The input into the primary sensory area is transferred to the association sensory area through processing in the secondary 
sensory  area. The output is produced in the association motor area in which the information is correlated with that in the 
limbic system (memory area). The output is processed in the secondary motor, and finally in the primary motor area, the 
actual response, action, or behavior is put forward to outside of the brain. 
                            Fig. 2 Cognitive function
Cognitive function can be classified into two categories : fluid and crystalized intelligence. Fluid 
intelligence is gradually declined in the elderly. Crystallized intelligence, however, is maintained in the 
elderly 
             Fig. 3 Fluid intelligence and crystalized intelligence
Aging and cognitive function 
 Generally speaking, cognitive function has been 
believed to decline with age in the elderly. It is 
not the case, however, every domain of cognitive 
function declines at the similar rate. Some  do-
main of cognitive function can be preserved even 
in the elderly. Cognitive function that is evalu-
ated traditionally as intelligence quotient (IQ) in 
the field of experimental psychology, is commonly 
divided into the two categories: fluid intelligence 
and crystallized intelligence. Fluid intelligence 
such as simple memory, and working memory, is 
subject to decline by aging in the elderly. But
crystallized intelligence such as common sense, 
reasoning, or judgment,is maintained even in the 
elderly. As shown in Fig. 3, some of the crystal-
lized intelligence can be improved even in the 
elderly.
Successful aging
 Humans are born as a baby that is similar to 
each other with little individual difference. Along 
with the life of humans through the staging of 
child, adolescence, adult and the elderly, education 
and experience are accumulated in life, resulting
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in significant individual differences in the elderly. 
The elderly show the widest range of individual 
difference, not only in physical ability, intellectual 
ability, or economic capacity, but also in social 
competence. 
 The World Health Organization (WHO) has 
proposed the term of  "  aging society" to the 
society with 7% or more elderly 65 years old and 
above. The society with 14% and more of the 
elderly is called "aged society". The society with 
21% or more of the elderly can be called  "super-
aged society". There has been lots of discussions 
on which life style is suitable for the elderly living 
in aged or super-aged society. Since significant 
difference exists in capacity of the elderly, the 
simple dichotomy between normal and abnormal 
is not enough to describe the life capacity of the 
elderly life. The concept of "successful aging", 
"
active aging," or "creative aging" is often 
discussed because the simple dichotomy is mis-
leading. Given the diversity of the individual 
difference in capacity of the elderly, the simple 
dichotomy, normal or diseased, is insufficient. 
Rather it is advisable to consider the elderly in the 
spectrum from "normal aging" through "success-
ful aging." 
 We had better describe an elder individual, 
placing a person to a certain point in the spectrum 
considering individual difference in the actual 
situation. Cognitive function is essential in the 
daily life of the elderly. In this context, an ex-
treme example of unsuccessful aging is dementia. 
 In order to achieve the successfulaging the 
following four conditions are required: (a) physical
(a) physical health, (b) normal cognitive function, (c) life satisfaction and 
happiness, and (d) social activities and social productivity are required 
for the successful aging. Above the physical health, cognitive health is 
the most important to attain successful aging. (b) normal cognitive 
function, (c) life satisfaction and happiness, and (d) social activities and 
social productivity are interrelated each other. 
             Fig. 4 Successful aging
health, (b) normal cognitive function, (c) life 
satisfaction and happiness, as well as (d) social 
activities and social productivity. Above all, 
maintaining the normal cognitive function is 
important o successful aging. As shown in Fig. 4, 
the interrelationship among normal cognitive 
function, life satisfaction and social activity have 
been previously discussed (Takeda et al. 2015).
Cognitive decline due to neurocognitive disorders 
 In  DSM-5, neurocognitive disorder has been 
proposed, which has a slightly broader meaning 
than dementia. As depicted in Fig. 5, the schema 
of cognitive decline due to neurocognitive disor-
der include the mild cognitive impairment (MCI) 
and subjective cognitive impairment (SCI) as the 
stage preceding dementia when social life, 
personal life and biological life capacities can be 
preserved. In dementia, personal ife capacity in 
addition to social life capacity is impaired, while 
biological ife capacity such as breathing, cardiac 
circulation, and other functions is preserved, 
required for humans to live biologically. 
 In mild cognitive impairment (MCI) as a pre-
stage of dementia, only social life capacity is 
impaired while the capacity for both personal ife 
and biological ife capacity is maintained. Before 
MCI, there is a stage of subjective cognitive 
impairment (SCI) in which memory function is 
slightly impaired compared with that in 30s of the 
individual. The complaint is mainly subjective, 
but full capacity in social life, personal life and 
biological ife is maintained (Fig. 5)
Cognitive impairment due to psychiatric disorders 
 Cognitive dysfunction is observed as the 
foreground symptom in neurocognitive disorders 
by definition. Dysfunction in cognition is, how-
ever, also observed in a number of psychiatric 
disorders other than dementia. Cognitive impair-
ment of psychiatric disorders has been attracting 
more attention as the core symptoms of the 
disorders. 
 In Fig. 6, the cognitive dysfunction in schizo-
phrenia is listed. Schizophrenia patients show 
severe dysfunction in verbal memory, executive 
function, alertness, and word fluency, dropped 
below 2-3 standard deviations (SDs) compared 
with the healthy control. On the other hands, the 
patients maintain the full capacity of word reading 
and word understanding, and long-term episodic 
memory (Fig. 6). 
 Cognitive capacity of the patients with major 
depression, anxiety disorder, and bipolar dis-
orders is shown in Fig. 7. Psychiatric patients all
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 SCI ; subjective cognitive impairment MCI ; mild cognitive impairment 
In subjective cognitive impairment (SCI), social life, personal life and biological ife capacity is preserved. In mild 
cognitive impairment (MCI). social life capacity is impaired but personal ife and biological life capacity is preserved. In 
dementia stage. sociallife and personal ife capacity are significantly impaired, but biological ife capacity is preserved. 
                      Fig. 5 Cognitive decline and life capacity.
Severe impairment (*) implies the mean value is 2-3 SD below than the control with matched age and education. 
Intermediate impairment (**) implies 1-2 SD below  than the control, and slight impairment (***) implies 0.5-1.0 SD below the control. 
(Roitmsan, Harvey, Keefe, 1997) 
                       Fig. 6 Cognitive impairment with schizophrenia
Fig. 7 Cognitive impairment with major depression, anxiety disorder, and bipolar disorder (Gorwood et al.2008)
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Fig. 8 Number of domains showing below 2 standard deviations (less than 70 points) by 
category of disorder 
(Gorwood  P, Corruble  E, Falissard B, Goodwin GM. Am J Psychiatry. 2008)
Fig. 9  Number of correct delayed recall responses at the second visit according to the 
 number of previous depressive episodes in patients with major depressive 
disorder 
(;Gorwood P, Corruble E, Falissard B, Goodwin GM. Am  J Psychiatry. 2008)
show dysfunction in all items studied including 
memory, psychomotor speed, response time, 
attention, and cognitive flexibility, with most 
significant dysfunction in attention. About 30.2% 
patients with bipolar disorder,  20.7% of major 
depression, and  19.0% of schizophrenia patients 
show below 2 SDs or more dysfunction in multiple 
items studied (Fig. 8). Patients with major 
depression often show repeated episodes of 
depression, and it is known that delayed recall is 
impaired by repeated depressive episode (Fig. 9). 
Introduction of DSM-5 
 American Psychiatric Association published 
DSM-5 in May 2013, which is the revision  of 
previous DSM-III (1980), DSM-IIIR (1987),  DSM-
IV (1994), and DSM-IV-TR (2000). DSM-5 is a 
major revision after 19 years since the publication 
of DSM-IV. In the revising process of DSM-5, 
there had been a fierce dispute between the 
supporters of categorical model and dimensional 
model. The proponents for the dimensional model 
insisted on the diversion from long-standing 
traditional dichotomy of schizophrenia nd mood 
disorders since Kraepelin's time by incorporating 
recent findings from biological psychiatry. The 
debate of  "deconstructing psychosis" itself is 
interesting and published in the literature. Many 
psychiatrists were involved in the discussion and 
there was much expectation that DSM-5 would 
eventually incorporate the outcome from the 
discussions on dimensional model. The an-
nouncement of DSM-5 has attracted a great deal
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of expectation. 
 After studying the published DSM-5, features 
of DSM-5 are summarized: (1) Transformation 
from categorical model to dimensional model 
approach was incompletely adapted, (2) Major 
items were sorted according to the life de-
velopment model, (3)Major items were arranged 
considering the internalizing and externalizing 
factors, (4) The multi-axial diagnostic system 
was abolished, (5) Many specifiers are available, 
(6) For the evaluation of general function of 
patients, WHO Disability Assessment Schedule 
(WHODAS) according to ICF is adapted and GAF 
scale has been abandoned. 
 Due to high pre-publication anticipation, many 
opinions have been issued and published since the 
publication of DSM-5. Typical comments from 
Europe are cited here by  Hans-Jorgen  Mo11er and 
his coworkers:  (1)  The original plan to introduce 
dimensional model was not completed and DSM-5 
was ended with the categorical model after all. (2) 
Biological findings such as biological markers, 
genetics, and brain imaging, were not sufficiently 
incorporated, and DSM-5 remained after all in the 
symptomatology-based descriptive classification. 
(3) The intention of introducing the dimensional 
approach was implemented by newly introduced 
"specifiers
." (4) DSM-5 is still unclear whether 
these specifiers are fully utilized in clinical 
settings  (Moller et al. 2014).
Difficulty in classification system of psy-
chiatric disorder
 Systemic classification of psychiatric disorder 
was first implemented by Emil Krapelin in 1920 
when he demarcated schizophrenia from manic 
depressive disorder. The difficulty in accurately 
classifying psychiatric disorders was pointed 
out by Krapelin himself from the beginning. 
Krapelin stated in his book;  "The method applied 
so far to define morbid forms, taking into account 
the course, manifestations, evolution and the final 
stage, and postmortem findings, is exhausted and 
is no longer satisfactory. New ways must be 
sought out" (Krapelin, 1920). 
 When DSM-IV-TR was announced, Steve-
Hyman, then US National Institute of Mental 
Health (NIMH) director stated;  "Approaches to 
diagnostic validity based on clinical description, 
laboratory studies, natural history of illness, and 
familial aggregation have not converted to yield a 
nosology based on valid disease entities. Defining 
a rational nosology for disorders of the brain is 
clearly one of the great challenges for modern
medical science (Hyman, 2002)." 
 After the publicationof DSM-5 in 2013, Juan 
and Maria Lopes-Ibor stated "The great hope that 
DSM-5 could bring fundamental advances in our 
understanding of the genetic and environmental 
determinants of disease risk, and of the neural 
circuity supporting normal and pathological 
mental processes has not been materialized in 
spite of extensive and intensive research efforts" 
(Lopes-Ibor et al. 2013a, 2013b).
Transition of classification systems 
tioning of DSM-5
and posi-
 When we look back the history, psychiatry has 
clearly been developed by repeated swings 
between biological psychiatry and psychological 
psychiatry like a pendulum. The period of early 
20th century when Emil  Krapelin proposed the 
two distinct entities of diseases, schizophrenia nd 
manic depressive disorder, was the time of new 
biology where neuropathology was brought in as 
the new research technique. In other words, it 
was the days of high expectation for psychiatry to 
be developed along with biological science. In 
those days, Karl Jaspers stated, "In order to 
understand the psychiatric disorder, not only the 
description of the causal relationship with brain 
science, there is a need for understanding of the 
meaning contained in the psychiatric symptoms. 
Mental disorders demand meaningful under-
standing as well as the causal explanation de-
livered by the brain science. Translation of the 
objective findings of the brain sciences to 
meaningful ife-world of every subjective exper-
ience is essential." (Jaspers, 1913). 
 In those days, the traditional psychiatry in Ger-
many had accumulated many findings obtained 
through primarily neuropathological techniques. 
The swing of psychiatry pendulum was swayed 
predominantly into the direction of biological 
psychiatry, and the new trend in psychological 
psychiatry was still in premature stage until 1945. 
Just before and during World War II, many 
psychiatrists who moved from Germany to the 
United States, promoted the rise of psychological 
psychiatry in the United States. Consequently, 
psychiatry in the 1960s was biased towards to 
psychological psychiatry, and the pendulum of 
psychiatry was swung too much to psychological 
psychiatry. It was in 1959 that WHO summoned 
the meeting on classification system of psychiatric 
disorders, where the reliability of the diagnostic 
system was seriously debated. Experts in 
classification of psychiatric disorders were asked
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Development of diagnostic classification system in psychiatry
for the means to increase the reliability of 
psychiatric diagnosis. As the important outcome 
from this meeting, a new classification system 
was proposed which could be used internationally 
with good reliability, and highly manipulative 
diagnostic system was developed as ICD-9 (1978) 
and DSM-III (1980), which was based on 
behaviors and symptoms observed from outside, 
trying to avoid any hypotheses or assumptions 
about the pathogenesis of psychiatric disorders. 
By effort of trying to attain objective diagnosis, 
psychiatry has returned to its pendulum again 
towards biological psychiatry, diverting from 
dependence on too much of psychology. 
 The next important step in revising clas-
sification system of psychiatric disorders was at 
the Dallas annual meeting of American Psy-
chiatric Association (APA) in 1997. At this meet-
ing, the corresponding measures to correct the 
negative effects of the DSM was put on the table, 
because serious negative feedback of DSM-III 
was the topics of the meeting. DSM-III was 
developed primarily to enhance the reliability of 
the diagnosis. The discussions were on the 
strategies how to enhance the validity of the 
diagnosis without losing the reliability of the 
diagnosis. Then the need for collaboration among 
clinicians, researchers, as well as patients and 
their families was proposed. This was the epoch-
making, breaking away from the swinging motion 
of the pendulum between biological psychiatry 
and psychological psychiatry in the past. This 
was the first time for psychiatry that a new
stance with an eye to social psychiatry was put to 
the front. In order to add diagnostic system more 
usefulness, the reliability should be sought for 
"fitti
ng for purpose" manner with collaborative 
work of patients, clinicians and researchers. The 
importance of the collaborative work was pointed 
out to evolve from descriptive diagnostic system 
to the theoretical diagnostic system. The impor-
tance of collaboration with patients and their 
family have been proposed (Fig. 10).
What is lost in DSM-5
 Given the complexity of psychiatric disorders, 
DSM-5 itself does not mean a completed final 
version, but is probably continued to be revised 
into future revisions until it reaches the full-
classification system. Further accumulation of 
knowledge and time will be needed for it. At the 
same time, the appropriate classification system is 
extremely important for the proper development 
of psychiatry itself, and the developed psychiatry 
will make further developed classification system 
feasible, vice versa. 
 Here, we point out some of the negative aspects 
that DSM-5 has brought in to research in 
psychiatry and neuroscience. As stated earlier, 
the primary goal of DSM-5 is to increase the 
matching rate of the diagnosis, i. e, higher 
reliability, which is attained by relying on 
observable symptomatology and statistical evi-
dence. For the sake of high reliability, DSM-5 is 
reluctant to incorporate new findings especially
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something based on theoretical thinking and 
biological findings. One drawback of DSM-5 is 
the lack of working hypothesis about the patho-
genesis of psychiatric disorders. In other words, 
the validity of the diagnosis is not always secured 
under DSM-5 classification system, which can be 
misleading to biological studies of psychiatric 
disorders. 
 The diagnosis under DSM-5 is not intended to 
promote an understanding of the pathophysiology 
of psychiatric disorders. Rather, the imperative 
procedure when the diagnosis is made is to 
increase the number of matched items described 
under a certain category of psychiatric disorder. 
This procedure can be sometimes misleading to 
understanding of the disease. For example, major 
depressive disorder is diagnosed with more than 
five out of the nine diagnostic items matched, but 
there is always a question whether major 
depressive disorder is really the same disease that 
meets different set of items in DSM-5 criteria. 
Another obstacle in DSM-5 is that there are too 
many comorbid disorders diagnosed to a single 
patient in actual clinical settings. It is important 
to notice that DSM-5 does not include the findings 
of biological psychiatry such as brain imaging, 
brain physiology, molecular genetics, and others. 
It is also important to know that DSM-5 is an 
operative diagnostic system simply relying on the 
set of symptoms or combination of syndrome, 
nothing to do with disease entity, which might 
mislead the direction of drug discovery research 
of psychiatric disorder if it is not properly de-
lineated.
Advocate of Research Domain Criteria (RDoC)
 Remarks by Thomas Insel, the current NIMH 
director, to DSM-5 had a significant impact in 
academia. He is the person representing 
biological psychiatry, and his opinion can be taken 
as the departure from DSM-5. Insel stated; "the 
diagnostic system has to be based on the 
emerging research data, not on the current 
symptom-based categories. For what we need to 
do in mental health research — for what it is 
becoming clear we can do  — the DSM approach is 
not appropriate. Even if it is still the best way to 
diagnose disorders and deliver treatment and knit 
the mental health care system together, it must 
begin to be supplanted by a new science-based 
framework" (Insel, 2013). 
 NIMH has launched the Research Domain 
Criteria (RDoC) project to transform diagnosis by 
incorporating enetics, imaging, cognitive science,
and other levels of information to lay the 
foundation for a new classification system. 
Through a series of workshops over the past 18 
months, Insel has tried to define several major 
categories for a new nosology. This approach 
began with several assumptions: 
• A diagnostic approach based on the biology as 
 well as the symptoms must not be constrained 
 by the current DSM categories, 
• Mental disorders are biological disorders 
 involving brain circuits that implicate specific 
 domains of cognition, emotion, or behavior, 
• Each level of analysis needs to be understood 
 across a dimension of function, 
• Mapping the cognitive circuit, and genetic 
 aspects of mental disorders will yield new and 
 better targets for treatment. 
 Thomas Insel and NIMH have launched the 
program for designing new diagnostic criteria of 
RDoC independent from for DSM-5 which is 
incorporating full utilization of recent knowledge 
in biological psychiatry. It aims for the elu-
cidation of the five neural networks; negative 
valence systems, positive valence systems, 
arousal / modulatory systems, cognitive systems, 
and systems for social processes, which can be 
eventually used for creating diagnostic criteria of 
psychiatric disorders.
Brain connectome and network analysis
 The Brain Activity Mapping Project in the 
United States and Human Brain Project of 
European Community were launched in 2013 with 
a huge budget investment. Even though these 
two projects are independently initiated, the goal 
of both projects are set to elucidate the brain 
specific function of human beings by analyzing all 
neural circuits in the brain by filling the gap 
between the intracellular electrode recording 
from a single neuron and the findings from brain 
functional imaging. It is expected to reveal the 
mechanism and function of neural circuit of the 
humans for the first time by analyzing the activity 
of every circuit consisting of numerous neurons. 
As the time schedule of Brain Mapping Project, it 
is expected to reveal the unique characteristics of 
neural circuit of the nematode (302 nerve cells), 
part of the brain circuit of Drosophila (15,000 
nerve cells), the circuit of the mouse retina (about 
50,000 nerve cells), and the circuit of mouse 
cerebral cortex slices (about 40,000 nerve cells) in 
five years. The whole brain of Drosophila (13.5 
million neurons), the central nervous system of 
fish (1 million neurons), the entire cortex of the
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Etruscan shrew (100 million units) will be attained 
in 10 years. Finally in 15 years, it is expected to 
decipher the circuit of the whole brain activity of 
mouse cerebral cortex to clarify the meaning of 
overall brain activity. 
 The present study of brain activity in humans 
has already shown that several sites are 
functioning cooperatively in the brain. Typical 
examples of brain circuit include: (1) the 
frontoparietal system involved in attention and 
cognitive control, (2) the cortical limbic system 
involved in emotional arousal and regulation, (3) 
the frontal striatal system involved in reward and 
motivation, and (4) the default-mode network 
(DMN) which is active during the state where 
nothing is seemingly executed but is believed to 
be involved in  self-expression and social cognition 
(Fig. 11). 
 Each neural circuit is related with some type of 
psychiatric disorders, and further related with the
function of several genes. For example, the 
neural circuit representing the cognitive domain 
is involved with working memory, goal-directing 
attention, and performance monitoring, which will 
cause inattention/ distractibility, working mem-
ory deficits, executive dysfunction when this 
neural circuit is impaired by disorders. Since the 
related genes are partly revealed in these 
disorders, neural circuit analysis could be the link 
between genetic information and the symptoms 
caused by the disorder (Fig. 12).
How to secure the
psychiatric disorders
validity in diagnosis of
 The goal of DSM-5 was, in simple words, to 
increase the matching rate of the diagnosis. The 
reliability of the diagnosis was set high priority, 
but the consideration of its validity remained 
insufficient. So, we should be equipped with the
 Frontoparietal  (LPFC-dACC-IPS), corticolimbic (LPFC-vmPFC/OFC/pgACC-amygdala),  frontostriatal  (LPFC-vMPFC/OFC-striatum), and 
    DMN (VMPFC-PCC-TPJ/iPL) circuits underpin core executive, affective, motivational, and social domains of cognition, respectively. 
    Heritable variation in the function of these circuits produces deficits in circuit-specific cognitive domains, which manifest as clinical 
    symptoms. Circuit-specific, but transdiagnostic, ognitive processes (cognitive domains) and symptoms (symptom domains) are shown for 
    each network. Allelic variants in MAOA, DRD2, and  ZNF804A are shown affecting specific networks that may account for their observed 
    pleiotropic effects, as indicated by available  data 
    (Joshua W. Buckholtz, Andreas Meyer-Lindenberg :Psychopathology and the Human Connectome : Toward a Transdiagnostic Model of Risk 
    For Mental Illness. Neuron, Volume 74, Issue 6, 2012, 990-1004) 
Fig.  11 Example of brain networks representing attention and cognitive control, emotional arousal and regulation, reward and 
      motivation, and default-mode network (DMN)
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Network-Specific Symptom Expression
Idealized radar plots depict connectivity within four core networks for executive, affective, motivational. and social  cognition, centered on 
 DLPFC, amygdala,  striatum, and VMPFC, respectively. Distance of each spoke from the center represents the magnitude of deviation in 
node-wise connectivity from  "normal." Functional connectivity is considered here as a normally distributed quantitative trait ; thus, "normal" can be thought of as the population mean. Units are arbitrary. Continuous variation in the function of these circuits leads to 
variability in expression of symptoms linked  to each network, ranging from "healthy" (unlikely to cause psychological dysfunction) to 
 "symptomatic" (associated with significant dysfunction,  impairment, or distress). 
(Joshua W.  Buckholtz, Andreas Meyer-Lindenberg :Psychopathology and the Human  Connectome : Toward a Transdiagnostic Model of 
Risk For Mental  IllnessNeuron, Volume 74, Issue  6, 2012, 990-1004) 
   Fig. 12 Variability in circuit-level connectivity leads to variability in network-specific symptom expression
means to secure the validity of our diagnosis when 
we use DSM-5 in actual clinical settings. 
 Looking back the history, diagnostic system 
based on the German traditional psychiatry was 
the process of choosing the diagnosis by close 
observation of theabnormal behavior of the 
patient, by extracting the elements relevant to the 
diagnosis, and compare the validity of the 
diagnosis, which is quite different by experience 
and knowledge of the psychiatrist. Psychiatrists 
were loaded with huge task of picking the right 
diagnosis that seems to best suit from his 
experience and thinking. Therefore, there was a 
drawback that diagnosis does not always match 
by the discretion of experience. To exclude the 
drawback of traditional diagnostic system, DSM 
excluded the reasoning about the pathological 
process of the patients as the subjective 
judgement of a psychiatrist. The operational 
process of diagnosis in DSM intentionally avoided 
the psychopathological thinking, it simply relies 
on the process of combining a plurality of 
behavioral abnormalities observed from outside,
so that the number of matching items in the 
criteria is maximized. This kind of operational 
pragmatism can be applied in the process of 
giving diagnosis relying on behavioral characteris-
tics and epidemiological evidence, without paying 
attention to psychopathological observation in the 
etiology and pathogenesis of psychiatric disorder. 
Several shortcomings of the operational diagnos-
tic criteria have been discussed for many years 
since DSM-III in 1990s. 
 The attitude of "high reliability, less validity" as 
seen throughout the DSMs certainly has con-
tributed to the improvement of the concordance 
rate of the diagnosis, but it pays less interest to 
psychopathological considerations of the patients. 
The important fact is that even if the higher 
matching rate of diagnosis is attained by DSM-5, 
we should be always cautious about the validity of 
the diagnosis. 
  What is validity of the diagnosis of psychiatric 
disorders ? In science it is not always easy to 
secure the validity. The validity of the diagnosis 
in psychiatry should be considered from the
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viewpoint of individuality, fitting in place, and 
suiting its purpose. Especially for the validity of 
the psychiatric diagnosis, many factors should be 
included; incidence, prevalence, predilection age, 
symptoms, signs, course, treatment response, and 
many others, which should be judged by a 
comprehensive manner. 
 Validity of psychiatric diagnosis should be 
sought in accordance with the purpose ("fit for 
purpose"), in consideration of the implications to 
the patient life, and the subjective experience of 
the patient. we would like to discuss the important 
points when considering the validity of psy-
chiatric diagnosis.
1. What is meant by psychiatric disorder 
 Unlike other physical diseases,psychiatric dis-
order is a disease of "living humans." Psychiatric 
disorder is, in a sense, a disease of the brain and 
mind. But at the same time, the patients with 
psychiatric disorder live their life together with 
the disease. Most of physical diseases are the 
disease of a specific organ, in which the functional 
defect of the organ can be restored by 
intervention, and the patient can recover their full 
activity when it is restored. But it is not the case 
with psychiatric disorders. A patient with 
psychiatric disorder is a patient as a whole. 
Psychiatric disorder cannot be distracted from 
the patient life and patient himself. As an 
extreme example, T. Szasz who advocated an 
anti-psychiatry movement in 70s, said that 
psychiatric patients were all those produced by 
society segregation and he argued that there is no 
psychiatric disorder. Of course his idea is no 
more accepted, but there could be the room for 
discussion of what the psychiatric disorders is, 
especially in the borderline zone of psychiatric 
disorder and/or personality disorder. 
 The meaning of psychiatric disorder is quite 
different even to psychiatrists by the field of 
biological, psychological or social psychiatry. 
Disease model is easily accepted by biological 
psychiatrists, but psychological model is easier to 
be accepted by psychological psychiatrists. 
Considering the difference in understanding of 
psychiatric disorder, we have to bear in mind the 
possibility that no psychiatric disorder has solid 
evidence that it can be the real disorder or disease 
in the similar sense of physical disease in which 
the disease can be detached from the existence of 
the humans. Psychiatric disorder is a complexity 
of disease, disorder, dysfunction, and handicaps of 
the person living in the society.
2. "Understanding" of complex psychiatric symp-
  toms 
 Psychiatric symptoms are expressed as 
abnormal behaviors in patient life as a multi-
layered structure. Given the complexity of the 
psychiatric symptoms, it should be considered 
from both the observation of the patient's 
behavior and also from the expression of 
subjective experience by the patient. Unfor-
tunately the remarks of the patient with 
psychiatric disorder have been unfairly evaluated. 
Because remarks by the patient with psychiatric 
disorder are sometimes difficult to be understood, 
often change depending on the situations, 
sometimes lack logical structure, the claims from 
the patients have been often ignored. Those 
subjective remarks and experience of the patient 
were not properly evaluated as those versatile 
objective evaluation. 
 Psychiatrists or clinical researchers are ex-
pected to acquire information from the patient 
and their family members. It is essential to colla-
borate with the patient for the successful 
translation of clinical experience to research. At 
least, it is essential from the side of clinicians and 
researchers to learn the subjective experience of 
the patient. Such efforts to acquire the infor-
mation about individual differences of patients 
living in the society, and the meaning of 
symptoms to patient life and their family is 
necessary. In this sense, clinicians and re-
searchers as expertise-by-training is expected to 
collaborate with the patient and family as the 
expertise-by-experience.
3. Reconsider the meaning of psychiatric symptom 
 For many chronic diseases, there are two 
different models of recovery; medical model and 
recovery model. Medical model means symptom 
suppression because medical treatment is mainly 
aimed for the suppression of the symptom. The 
other is recovery model in which more attention is 
paid to quality of life (QoL) rather than the 
symptom suppression. The divergence between 
the above two models are often observed with 
chronic diseases. Dissociation between medical 
and recovery model is often seen in psychiatric 
disorders, and the symptom suppression and QoL 
do not necessarily correlated each other in psy-
chiatric disorders. 
 Here we would like to raise the question wheth-
er all psychiatric symptoms are worthless. Some 
novelists or artists in hypomanic state create 
high-quality works. Autism patients might have 
difficulty in interpersonal relationship in their
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working place, but they are good in giving calm 
judgment without being bound to human re-
lations. In some information technology com-
panies, an individual with autistic tendency is 
evaluated highly for their efficiency in the work 
requiring fine attention such as productive line of 
printed base of electronics. Schizophrenic 
patients can be engaged silently in a simple and 
tedious work. Given such examples, we cannot 
say that all of psychiatric symptoms is worthless. 
Some of psychiatric symptoms need to be 
reconsidered in terms of extending the advantage 
due to psychiatric symptoms and those to be 
controlled. Meaning and value of psychiatric 
symptoms are necessary to be reconsidered when 
we think about the patient's QoL and well-being.
History of intervention and treatment of psy-
chiatric disorders
 Until the early 19th century when Filipe Pinel 
released the chain of the patients with psychiatric 
disorders, disabled persons with psychiatric dis-
orders were not recognized even as human 
beings. With the statement of Binswanger that 
"
psychiatric disorder is a disease of the brain," 
patients with psychiatric disorders were for the 
first time recognized as the person dysfunctioned 
by brain disease. However, during the first half of 
the 20th century, there had been nothing as the 
effective treatment of psychiatric disorders. It 
was only in the second half of the last century 
when the development of anti-psychotic drugs 
was initiated in 1950s so that the first effective 
therapeutic intervention was applied to psy-
chiatric disorders. 
 Representative of the first generation of anti-
psychotic drugs was  chlorpromazine discovered 
by Delay and Deniker, pioneers in psycho-
pahrmacology. It was understood that anti-
hallucination/ delusion action is observed for the 
dopamine D2 receptor antagonists, and it became 
possible to reduce the pathological experience of 
many patients with schizophrenia. However, 
drug-induced Parkinsonism as an adverse side 
effects of the D2 blockers was at the same time 
popular, and side effects of extrapyramidal 
symptoms were forced to the patients for 
therapeutic effect. The side effects of D2 blockers 
were admitted inevitable for the sake of improve-
ment in psychiatric symptoms for many years. 
When we stand in the position of the patients, 
auditory hallucinations and delusions were cer-
tainly reduced with pharmacotherapy, but there 
was also inconvenience of extrapyramidal symp-
toms at the same time which was brought about 
by the drug usage. Many of the psychiatrists 
considered such inconvenience of patients to be 
endured for the sake of control of pathological 
 experience. 
 It was only after the introduction of the second-
generation anti-psychotic drugs that unwanted-
extrapyramidal symptoms were believed to be 
avoided, it was the initial phase of pharma-
cotherapy to listen to subjective experience of the 
patient. Then, in the second-generation of anti-
psychotic drugs, a few agents having an effect to 
the negative symptoms even incomplete were 
developed in addition to the effect to the positive 
symptoms. It has made it possible to listen to the 
voices of the patients on their experience, who 
have been significantly suppressed to raise the 
voice due to lack of spontaneous subjectivity. 
Considering the history of development of 
pharmacotherapy over half a century from the 
introduction of the first drug, we have finally 
reached the stage where we psychiatrists can try 
to hear the experience of thepatient as his own 
voice. 
 A similar situation is also true for the 
development of antidepressants. Imipramine was 
surendipitously developed in the 1950s as the first 
tricyclic antidepressant. Many tricyclic anti-
depressants were developed following imipra-
mine, all of which had adverse side effects mainly 
due to its anticholinergic effects. The tetracyclic 
antidepressants were then developed for the 
relief of adverse side effects. Now we are using 
many kinds of serotonin selective re-uptake 
inhibitors (SSRIs) as the first choice to treat the 
depressive patients. Antidepressant effect of 
SSRIs might be substantially the same as that of 
tricyclic antidepressants but adverse side effect of 
SSRI has been significantly reduced.The introduc-
tion of the antidepressants with reduced side 
effects, has led to major changes in drug therapy 
for depression. It was not possible for the de-
pressed patients to raise the voice for the symp-
toms, but now for the first time the subjective 
experience of the depressed patients can be heard 
by the use of suitable antidepressants.
Collaboration between clinicians, researchers, 
patients and their families 
 Collaboration of clinicians and researchers with 
patients and family members will be required for 
the future development of psychiatry. When we 
recall the words of Jaspers in 1913, "to psychiatric 
disorder, it is necessary to understand the 
meaning of the disease as well as description of
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the causal relationship that is brought about by 
the knowledge of brain science, " (Jaspers, 1913) 
 The author's proposal may not be new because 
the message is more or less similar with that of K. 
Jaspers, but I would like to point out that we are 
finally in the time where we can hear the voice of 
the patient owing to the advance in phar-
macotherapy. Our clinical situation allows us to 
listen to the patient's voice to understand the 
patients experience into research. The future of 
psychiatry depends how properly we will 
evaluate the subjective experience of the patient. 
It would be important to wear the ability to 
perceive and to understand the meaning of 
psychiatric symptoms.
 course, we should not forget the point of view of
the patient.
2. Which area should be  evaluated? 
 Psychiatric symptoms are complex enough in 
themselves. Patients may show symptoms of 
various areas such as behavioral abnormality, 
cognitive dysfunction emotional instability, mak-
ing invocation, and others. When we evaluate the 
effect of intervention, we should be careful enough 
to choose which areas of symptoms should be 
evaluated. There can be measures for subjective 
satisfaction, stability of the patient's emotion, 
cognitive function, the patient's health, inter-
personal relationship, and social services utiliza-
tion.
How we should evaluate psychiatric symptoms
 In the long history of psychiatric service in 
the past, psychiatrists had struggled for the 
objective evaluation of the patients, and in return, 
psychiatrists have truncated too much the sub-
jective experience of patients. Now it is the time 
for psychiatrists and researchers to collaborate 
with patients and families. It might be the only 
way for future psychiatry to promote collabora-
tion to evaluate properly the experience of the 
patient. 
 Evaluation of psychiatric symptoms can be 
done in objective way and in subjective way. 
Many kinds of scales and measures exist to be 
used in clinical settings of psychiatry. Any 
measures or scales can be used for different 
purposes in different clinical settings. Regardless 
of measures and scales, understanding of the 
patient as a whole is the most important to 
evaluate the effect of the psychiatric therapeutic 
interventions, and the following points should be 
born in mind.
1. Whose  outcome? 
 The most important viewpoint is whose 
outcome should be evaluated when we need to 
evaluate the effect of the intervention. Psy-
chiatric disorder is itself complex, and there might 
be instances where the effect of therapeutic 
intervention may be evaluated from the society's 
view point as a whole rather than for the patient. 
In the past in some countries, there used to be 
policies for psychiatric disorder which deviated 
significantly from the patients' point of view, 
rather it was discussed from the view point of 
caregivers, medical staff, or the community. 
However, in order for psychiatry to grow as 
useful service to the patients in the true sense, of
3. In which  level? 
 Psychiatric disorder may induce dysfunction at 
any levels in the hierarchy of biological, 
psychological, or social structure. In accordance 
with the respective methods of intervention, we 
should pay more attention to which level should 
be selected to evaluate the intervention effect at 
any level, such as individual level, interpersonal 
level, or society level in the whole. For the 
evaluation of individual level, we will pay more 
attention to the symptom changes, but when we 
are talking about interpersonal level, there might 
be the relationship with the carers, family 
members, or the thing in community networks 
can be evaluated. In addition, when we evaluate 
on the society level, prejudice, or stigma also can 
be considered as important measures for inter-
vention.
4. Symptom suppression model versus recovery 
  model 
 In many acute physical diseases, recovery 
from impaired function will usually be the same 
with the suppression of the symptoms, which 
is not necessarily the case in chronic diseases 
such as psychiatric disorders. For example, in a 
case of colon cancer, surgical treatment is 
recommended to save the life of the patients. 
Surgery can be the choice of treatment of 
cancer by excising cancer tissue, but the patient 
may face with inconvenience of reconstructed 
bladder and/ or artificial anus which may reduce 
the QoL of the patients. For psychotic patients, a 
large amount of psychotropic drugs may be 
prescribed in order to suppress hallucination or 
delusion, but there are cases where physical 
fatigue and sleepiness appear by a large dose of 
pharmacotherapy. Generally speaking, suppres-
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sion of hallucination/delusion to a certain level 
with minimum dose of antipsychotics is better for 
the patient quality of life even though high dose of 
the drug is necessary to have the complete sup-
pression of psychotic symptoms. This is not a 
simple choice between symptom suppression 
model or recovery model as an alternative choice. 
Rather we recommend to include the evaluation 
of subjective experience of the patient, such as 
HONOS, CORE-OM, OQ-45, and CAN.
5. Individual versus overall evaluation 
 Since psychiatric symptoms are complex, many 
rating scales are developed to evaluate the 
symptoms in distinct areas of mental function. 
But mental function of the patient is not the 
simple summation of individual score of each 
mental function. The eventual evaluation of the 
patients should be aimed to know how the 
patients are happy as a whole. The evaluation as 
a whole person is more meaningful as the 
evaluation of intervention rather than the in-
dividual area. Evaluation as the entire human 
beings should be used, such as goal attaining scale 
(GAS), Personal Primary Outcome (PPO) list, or 
INSPIRE score.
6. Disadvantage versus advantage 
 To evaluate overallfunction of the patients, 
there might be two different approaches, one is to 
evaluate the defect, and the other to evaluate 
advantage. When we are dealing with the 
patients showing some defect due to certain 
biological disease such as cerebral infarction in 
certain areas, it is easily understood by evaluating 
the defect caused by the disease. We can easily 
understand the direct causal relationship of the 
defect of the patients and the effect of interven-
tion. In most of complex symptoms of psychiatric 
patients, however, we may be sometimes lead to 
wrong conclusions if we pay our attention only to 
unnecessarily deficiency alone. Evaluating the 
advantage of the patients may often lead the 
correct evaluationas overall proactive experience. 
Subjective Happiness Scale, WHO-5 Well-being 
Index, Warwick-Edinburgh Mental Well-Being 
Scale (WEMWBS) can be used for the index which 
can give the information from the patients as the 
subjective experience as a whole.
7. Who's view point 
 Subjective experience of the patient will be 
more important for the future psychiatry than 
ever. Patient rated experience measures (PREM), 
patient rated outcome measures (PROM), patient-
generated PROM (PG-PROM) can be used more 
in clinical settings to emphasize the patient's 
viewpoint.
How to attain the proper understanding of 
psychiatric symptoms
 Human behavior is defined by the equilibrium 
between the inner impulse and the cognition of 
outside stimuli. Although the behavior of most of 
the healthy people falls within a certain range, the 
behavior of psychiatric patients might deviate 
from the range of such a healthy person. When 
internal impulse is too strong, or perception of 
external stimulus is inappropriate, the behavior of 
the patient is deviated significantly from the 
average value (Fig. 13). When we consider human 
behavior together with the notion of neural 
circuitry of the brain, we can draw a schema as 
depicted previously in Fig. 12. Human behavior is 
defined by the network activity of each region, the 
activities of each of the network defined by the 
stable state of each domain. In the brain circuitry 
recognizing external stimuli, there might be 
several alternate stable states. Then, by 
psychiatric disorder, we think the network steady 
state is stable beyond the scope of normal person. 
 To correctly understand the meaning of the 
psychiatric symptoms, it would be necessary 
to expand the framework of the observers' 
common sense. For this purpose, it is required 
to enlarge the width of the activities for each of 
the brain network as shown in Fig. 14. Listening 
to the voice of the patient, and trying to 
understand the subjective experience of the 
patient is helpful to increase empathy with the 
patients, and it may help broaden the width of 
such brain network. 
 As said by Jaspers, it is important to under-
stand the meaning of psychiatric symptoms. 
Trying to interpret the words by Jaspers in a 
modern sense, I would like to conclude the paper 
by the comments below. 
 It is importantto perceive and understand the 
subjective experience of the patient, and the 
subjective experience of the patient should be 
properly evaluated by psychiatrists, which is the 
only way to implement the patient-centered 
service. In addition, psychiatrists, as profession-
als facing the patients with psychiatric disorder, 
are expected to increase their ability of under-
standing by broaden the framework of their 
common sense, so that they can perceive, 
sympathize, and understand the voice from the 
patients.
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Normal 
behavior
Normal behavior Abnormal
Normal behavior is produced 
in equilibrium between 
internal and external dactors.
behavior
Human behavior is selected and produced as the equilibrium of internal impulse and external factors. The output behavior is 
ranged in certain range around the mean output as the normal behavior. In psychiatric patients, the output of behavior can be 
out of the common range, below or over 2 standard deviations, which is sometimes  understood by the people. There are 
several steady states of the brain network which produces normal and abnormal behaviors. 
                      Fig. 13 Output mechanism of human behavior
Executive 
network
Reward and 
Motivation  network
Range of normal behavior 
within common sense
Affective 
network
Self-representative 
Social cognition network
Psychiatric abnormal behavior 
out of the common sense
Widened range of common 
sense expected to psychiatrist
The common range of behavior is the product of several brain networks including executive, affective, reward and 
motivation, and self-representation. Each domain can be abnormal with psychiatric patients. To properly understand the 
meaning of these psychiatric symptoms, psychiatrists themselves are expected to expand the range of these networks. 
                                   Fig. 14
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